Wealthcare Advisory Partners LLC Cytosorbents Corp Transaction History

Wealthcare Advisory Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$4.05 - $8.11 $251,857 - $504,336	-62,187 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$3.77 - $7.73 $346 - $711	-92 Reduced 0.15%	62,187 $481,000
Q3 2019 Oct 17, 2019	BUY	$4.33 - $7.63 $866 - $1,526	200 Added 0.32%	62,279 $313,000
Q1 2018 May 15, 2018	BUY	$6.55 - $8.2 $20,829 - $26,075	3,180 Added 5.4%	62,079 $438,000
Q3 2017 Nov 15, 2017	BUY	$4.5 - $6.2 $265,045 - $365,173	58,899	58,899 $365,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.